EGFR and lung adenocarcinoma: <b>Case presentation</b>: The first case was of a 58-year-old male with advanced lung adenocarcinoma (cT4bN3M1b) with exon 18 G719X and exon 20 S781I <i>EGFR</i> mutations and received afatinib therapy.